Literature DB >> 8694088

Histopathologic and immunohistochemical analysis of the filtration bleb after unsuccessful glaucoma seton implantation.

L Classen1, T Kivelä, A Tarkkanen.   

Abstract

PURPOSE: To analyze histopathologically and immunohistochemically the filtration bleb after unsuccessful glaucoma seton implantation.
METHODS: A von Denffer implant and two Molteno implants that were nonfunctional at three months, at 11 months, and at five years after implantation, respectively, were compared by evaluating the adjacent bleb with light microscopy and a panel of 11 antibodies to epithelial, mesenchymal, and inflammatory cells.
RESULTS: The wall of the filtration bleb three months after implantation consisted of loosely arranged collagenous connective tissue with relatively abundant fibroblasts labeled with monoclonal antibodies (MAbs) V9 and Vim 3B4 to vimentin. At 11 months and at five years, the collagenous layers had become increasingly thick and the fibroblasts scarce. All blebs showed metaplastic myofibroblasts surrounded by tenascin, as identified by MAb 1A4 to alpha-smooth muscle actin and TN2 to tenascin, respectively. One bleb was lined by a monolayer of cells that reacted with MAb CAM 5.2 and CY-90 to cytokeratin 8 and 18, respectively, and was apparently derived from the identically reacting proliferating corneal endothelial cells. Another bleb harbored many macrophages and foreign-body giant cells. Little evidence of chronic inflammation around the seton was detected.
CONCLUSIONS: A glaucoma seton may induce several processes that potentially decrease filtration. In addition to formation of a collagenous cyst, presence of myofibroblasts suggests long-standing scar modulation that potentially leads to compaction of the filtration membrane. Furthermore, macrophages and corneal endothelial cells may invade the filtration bleb.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694088     DOI: 10.1016/s0002-9394(14)72011-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Survival analysis for success of Molteno tube implants.

Authors:  D C Broadway; M Iester; M Schulzer; G R Douglas
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  Suprachoroidal implant surgery in intractable glaucoma.

Authors:  Melis Palamar; Halil Ates; Zafer Oztas; Emil Yusifov
Journal:  Jpn J Ophthalmol       Date:  2011-05-27       Impact factor: 2.447

Review 3.  [Glaucoma drainage devices].

Authors:  H Thieme
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

4.  Altered expression of fibrosis genes in capsules of failed Ahmed glaucoma valve implants.

Authors:  Alka Mahale; Maha W Othman; Sami Al Shahwan; Ibrahim Al Jadaan; Ohood Owaydha; Zahid Khan; Deepak P Edward
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

5.  Histopathologic and immunohistochemical features of capsular tissue around failed Ahmed glaucoma valves.

Authors:  Alka Mahale; Fatma Fikri; Khitam Al Hati; Sami Al Shahwan; Ibrahim Al Jadaan; Hind Al Katan; Rajiv Khandekar; Azza Maktabi; Deepak P Edward
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

6.  Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C.

Authors:  Sharmila Rajendrababu; Sujani Shroff; Sangeeta Vivek Patil; Mohammed Sithiq Uduman; Ashok Vardhan; S R Krishnadas
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

7.  Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique.

Authors:  Minwen Zhou; Wei Wang; Wenbin Huang; Xiulan Zhang
Journal:  BMC Ophthalmol       Date:  2014-09-06       Impact factor: 2.209

Review 8.  Magnetic Resonance Imaging Study on Blebs Morphology of Ahmed Valves.

Authors:  Joana Ferreira; Fernando Fernandes; Madalena Patricio; Ana Brás; Cristina Rios; Ingeborg Stalmans; Luis Abegão Pinto
Journal:  J Curr Glaucoma Pract       Date:  2015-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.